"10.1371_journal.pone.0019617","plos one","2011-05-10T00:00:00Z","Cynthia Gay; Oliver Dibben; Jeffrey A Anderson; Andrea Stacey; Ashley J Mayo; Philip J Norris; JoAnn D Kuruc; Jesus F Salazar-Gonzalez; Hui Li; Brandon F Keele; Charles Hicks; David Margolis; Guido Ferrari; Barton Haynes; Ronald Swanstrom; George M Shaw; Beatrice H Hahn; Joseph J Eron; Persephone Borrow; Myron S Cohen","Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America; Nuffield Department of Clinical Medicine, University of Oxford, Weatherall Institute for Molecular Medicine, Oxford, United Kingdom; Blood Systems Research Institute, San Francisco, California, United States of America; University of California San Francisco, San Francisco, California, United States of America; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Duke University, Durham, North Carolina, United States of America","Conceived and designed the experiments: CG JA BH RS PB MC. Performed the experiments: OD JA AS PN JS HL BK GF BHH. Analyzed the data: CG OD JA AS AM JK MC PB. Contributed reagents/materials/analysis tools: OD JA AS PN JK JS HL BK CH DM GF BHH RS GS BH JE PB MC. Wrote the paper: CG JA AM CH DM GF BH GF JE PB MC. Edited manuscript: JA PN JK BK CH DM GF RS GS JE PB MS.","C.G. has received research support from Bristol Myers Squibb and Gilead Sciences for studies which participants in this study could co-enroll on, but not for the CHAVI 001 study. C.H. has received grant support and/or consulting/honoraria from BMS, GSK, Merck, Tibotec, Gilead, Myriad Pharmaceuticals, Pfizer, none of which is related to this study. D.M. has received research support from Bristol Myers Squibb, Gilead Sciences, Merck, Abbott, and Roche, but none for this study, and is a honoraria for professional services to Bristol Myers Squibb, Merck, Chimerix, and Tibotec Therapeutics. J.E. receives research support from Merck and GlaxoSmithKline which is not related to this study and is a consultant to Bristol Myers Squibb, Merck, and Tibotec Therapeutics. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have no competing interests to declare.","2011","05","Cynthia Gay","CG",20,FALSE,6,9,8,10,TRUE,TRUE,FALSE,0,NA,FALSE
